1Sawada Y,Nasu R,Matsuo H,et al.Relationship between structure and drug-induced parkinsonism[].Ann Pharmaco-ther.2000
2Vaamonde J,Ibá?ez R,Gudin M,et al.Fluctuation and dyskinesias as early L-dopa-induced motor complications in severe Parkinson‘s patients[].Neurologia.2003
3Bonham C,Abbott C.Are second generation antipsychotics a distinct class[J]?[].J Psychiatr Pract.2008
4Leucht C,Kitzmantel M,Chua L,et al.Haloperidol versus chlorpromazine for treatment of schizophrenia[].Schizophrenia Bulletin.2008
5Johnsen E,Jorgensen HA.Effectiveness of second generation antipsychotics:a systematic review of randomized trials[].BMC Psychiatry.2008
6Meltzer HY,Huang M.In vivo actions of atypical anti-psychotic drug on serotonergic and dopaminergic systems[].Progress in Brain Research.2008
7Correll CU.Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents[].Journal of Clinical Psychiatry.2008
8Giroud BJZ,Lopez KM,Mendzz CA,et al.Clinical cha-racteristics of drug induced parkinsonism in psychotic patients[].Revue Neurologique.2001
9Pollak P,Tison F,Rascol O,et al.Clozapine in drug induced psychosis in Parkinson‘s disease:a randomised,placebo controlled study with open follow up[].Journal of Neurology Neurosurgery and Psychiatry.2004
10Tandon R,Belmaker RH,Gattaz WF,et al.World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia[].Schizophrenia Research.2008
